Company profile for Kintor Pharmaceutical

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Pioneer Pharmaceutical was established in 2009, focusing on the development and industrialization of potential "best-in-class" and "first-in-class" innovative drugs, and is committed to becoming a leader in the research, development and commercialization of innovative therapies. The company was founded by national talents. After years of development, the company has developed a multi-channel product portfolio with androgen ...
Pioneer Pharmaceutical was established in 2009, focusing on the development and industrialization of potential "best-in-class" and "first-in-class" innovative drugs, and is committed to becoming a leader in the research, development and commercialization of innovative therapies. The company was founded by national talents. After years of development, the company has developed a multi-channel product portfolio with androgen receptor (AR) related diseases as the core. The products cover the global high incidence of cancer and other diseases that do not meet clinical needs, including Prostate cancer, breast cancer, liver cancer and hair loss.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
4th Floor, Building C4, Biomedical Industrial Park, No.218 Xinghu Street, Suzh...
Telephone
Telephone
0512-62956307
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/phase-ii-stage-of-pivotal-clinical-trial-of-kx-826-tincture-1-0-for-the-treatment-of-male-adult-aga-in-china-reached-primary-endpoint-302513815.html

PR NEWSWIRE
25 Jul 2025

https://www.prnewswire.com/news-releases/gt20029-china-phase-ii-trial-for-aga-reached-primary-endpoint-302122889.html

PR NEWSWIRE
21 Apr 2024

https://www.prnewswire.com/news-releases/study-of-kintors-c-myc-degrader-published-in-subsidiary-journal-of-nature-302088904.html

PR NEWSWIRE
13 Mar 2024

https://www.prnewswire.com/news-releases/kintor-pharma-announces-the-approval-for-phase-ii-clinical-trial-of-hedgehogsmo-inhibitor-gt1708f-for-treatment-of-ipf-in-china-301953381.html

PR NEWSWIRE
11 Oct 2023

https://www.prnewswire.com/news-releases/kintor-pharma-announces-completion-of-patient-enrollment-in-phase-ii-clinical-trial-of-gt20029-for-treatment-of-androgenetic-alopecia-in-china-301906583.html

PR NEWSWIRE
22 Aug 2023

https://www.indianpharmapost.com/news/kintor-pharma-completes-first-patient-enrollment-in-long-term-safety-phase-iii-trial-of-kx-826-14409

INDIAN PHARMA POST
21 Jul 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty